Evaluation of brain iron content based on magnetic resonance imaging (MRI): Comparison among phase value, R2* and magnitude signal intensity

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Yan, Shen Qiang ^a   Sun, Jian Zhong ^a   Yan, Yu Qing ^a   Wang, He ^b   Lou, Min ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b GE HEALTHCARE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; ARTICLE; BRAIN IRON CONTENT; BRAIN MAPPING; BRAIN REGION; CONTROLLED STUDY; FEMALE; GLOBUS PALLIDUS; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE PROCESSING; INTERMETHOD COMPARISON; IRON BLOOD LEVEL; IRON STORAGE; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PUTAMEN; RED NUCLEUS; SUBSTANTIA NIGRA; SUSCEPTIBILITY WEIGHTED IMAGING; THREE DIMENSIONAL IMAGING; AGED; BRAIN; COMPARATIVE STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; SIGNAL PROCESSING;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; FEMALE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 84857437404     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031748     Document Type: Article

References (32)

1. Bothwell TH, (1995) Overview and mechanisms of iron regulation. Nutr Rev 53: 237-245.
2. Andrews NC, (1999) Disorders of iron metabolism. N Engl J Med 341: 1986-1995.
3. Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, et al. (2001) Ferritin and the response to oxidative stress. Biochem J 357: 241-247.
4. Altamura S, Muckenthaler MU, (2009) Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. J Alzheimers Dis 16: 879-895.
5. Drayer B, Burger P, Darwin R, Riederer S, Herfkens R, et al. (1986) MRI of brain iron. AJR Am J Roentgenol 147: 103-110.
6. Haacke EM, Chengb NYC, House MJ, Liu Q, Neelavalli J, et al. (2005) Imaging iron stores in the brain using magnetic resonance imaging. Magnetic Resonance Imaging 23: 1-25.
7. Stankiewicz J, Panter SS, Neema M, Arora A, Batt CE, et al. (2007) Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 4: 371-386.
8. Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, et al. (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37: 899-909.
9. Duce JA, Bush AI, (2010) Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics. Prog Neurobiol 92: 1-18.
10. Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, et al. (2010) Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142: 857-867.
11. Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF, (2003) Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab 23: 629-652.
12. Nakamura T, Keep RF, Hua Y, Nagao S, Hoff JT, et al. (2006) Iron-induced oxidative brain injury after experimental intracerebral hemorrhage. Acta Neurochir Suppl 96 pp. 194-198.
13. Hua Y, Keep RF, Hoff JT, Xi G, (2007) Brain injury after intracerebral hemorrhage: the role of thrombin and iron. Stroke 38: 759-762.
14. Lou M, Lieb K, Selim M, (2009) The Relationship between Hematoma Iron Content and Perihematoma Edema: An MRI Study. Cerebrovascular Diseases 27: 266-271.
15. Bartzokis G, Aravagiri M, Oldendorf WH, Mintz J, Marder SR, (1993) Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med 29: 459-464.
16. Haacke EM, Xu Y, Cheng YC, Reichenbach JR, (2004) Susceptibility weighted imaging (SWI). Magn Reson Med 52: 612-618.
17. Ogg RJ, Langston JW, Haacke EM, Steen RG, Taylor JS, (1999) The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging 17: 1141-1148.
18. Haacke EM, Ayaz M, Khan A, Manova ES, Krishnamurthy B, et al. (2007) Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging 26: 256-264.
19. Xu X, Wang Q, Zhang M, (2008) Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study. Neuro Image 40: 35-42.
20. Pfefferbaum A, Adalsteinsson E, Rohlfing T, Sullivan EV, (2009) MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuro Image 47: 493-500.
21. Langkammer C, Krebs N, Goessler W, Scheurer E, Ebner F, et al. (2010) Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 257: 455-462.
22. Yao B, Li TQ, Gelderen P, Shmueli K, de Zwart JA, et al. (2009) Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuro Image 44: 1259-1266.
23. Hallgren B, Sourander P, (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3: 41-51.
24. Bizzi A, Brooks RA, Brunetti A, Hill JM, Alger JR, et al. (1990) Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths. Radiology 177: 59-65.
25. Jin L, Wang J, Zhao L, Jin H, Fei G, et al. (2010) Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. Brain 134: 50-58.
26. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, et al. (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114 (Pt 4): 1953-1975.
27. Berg D, Hochstrasser H, (2006) Iron metabolism in Parkinsonian syndromes. Mov Disord 21: 1299-1310.
28. Rhodes SL, Ritz B, (2008) Genetics of iron regulation and the possible role of iron in Parkinson's disease. Neurobiol Dis 32: 183-195.
29. Liu T, Spincemaille P, de Rochefort L, Kressler B, Wang Y, (2009) Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI. Magn Reson Med 61: 196-204.
30. de Rochefort L, Liu T, Kressler B, Liu J, Spincemaille P, et al. (2010) Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn Reson Med 63: 194-206.
31. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC, (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 30: 19-30.
32. Hasan KM, Walimuni IS, Kramer LA, Narayana PA, (2011) Human brain iron mapping using atlas-based T(2) relaxometry. Magn Reson Med.